EMA-HMA Biosimilar Interchangeability Statement Offers ‘Unity And Clarity’ For Europe
Provides Foundation For Uptake Ahead Of Upcoming EU Pharmaceutical Legislation Reform
• By David Wallace
Isabell Remus says the EMA-HMA statement brought “relief and joy” • Source: Medicines for Europe 
